BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9215803)

  • 1. Clastogenic factors in plasma of HIV-1 infected patients activate HIV-1 replication in vitro: inhibition by superoxide dismutase.
    Edeas MA; Emerit I; Khalfoun Y; Lazizi Y; Cernjavski L; Levy A; Lindenbaum A
    Free Radic Biol Med; 1997; 23(4):571-8. PubMed ID: 9215803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clastogenic factors in plasma of HIV-1 infected patients.
    Fuchs J; Emerit I; Levy A; Cernajvski L; Schöfer H; Milbradt R
    Free Radic Biol Med; 1995 Dec; 19(6):843-8. PubMed ID: 8582657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparameter analysis of clastogenic factors, pro-oxidant cytokines, and inflammatory markers in HIV-1-infected patients with asymptomatic disease, opportunistic infections, and malignancies.
    Fuchs J; Oelke N; Imhof M; Ochsendorf F; Schöfer H; Oromek G; Alaoui-Youssefi A; Emerit I
    Mol Med; 1998 May; 4(5):333-43. PubMed ID: 9642683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lecithinized superoxide dismutase: an inhibitor of human immunodeficiency virus replication.
    Premanathan M; Nakashima H; Igarashi R; Mizushima Y; Yamada K
    AIDS Res Hum Retroviruses; 1997 Mar; 13(4):283-90. PubMed ID: 9071427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis.
    Ho JL; He S; Hu A; Geng J; Basile FG; Almeida MG; Saito AY; Laurence J; Johnson WD
    J Exp Med; 1995 Apr; 181(4):1493-505. PubMed ID: 7699332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcal superantigens activate HIV-1 replication in naturally infected monocytes.
    Goujard C; Wallon C; Rudent A; Boué F; Barre-Sinoussi F; Delfraissy JF
    AIDS; 1994 Oct; 8(10):1397-404. PubMed ID: 7818810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential requirements for HIV-1 replication in naive and memory CD4 T cells from asymptomatic HIV-1 seropositive carriers and AIDS patients.
    Cayota A; Vuillier F; Scott-Algara D; Feuillie V; Dighiero G
    Clin Exp Immunol; 1993 Feb; 91(2):241-8. PubMed ID: 8094041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-10 enhances human immunodeficiency virus type 1 expression in a chronically infected promonocytic cell line (U1) by a tumor necrosis factor alpha-independent mechanism.
    Angel JB; Saget BM; Wang MZ; Wang A; Dinarello CA; Skolnik PR
    J Interferon Cytokine Res; 1995 Jun; 15(6):575-84. PubMed ID: 7553227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen radical scavengers inhibit clastogenic activity induced by sonication of human serum.
    Pinamonti S; Chicca MC; Muzzoli M; Papi A; Fabbri LM; Ciaccia A
    Free Radic Biol Med; 1994 Mar; 16(3):363-71. PubMed ID: 8063200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte-derived clastogenic factor in rheumatoid arthritis.
    Emerit I; Levy A; Camus JP
    Free Radic Biol Med; 1989; 6(3):245-50. PubMed ID: 2744575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superoxide-mediated clastogenesis and anticlastogenic effects of exogenous superoxide dismutase.
    Emerit I; Garban F; Vassy J; Levy A; Filipe P; Freitas J
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12799-804. PubMed ID: 8917499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of L-lysine amino acid on the HIV-1 RNA replication in vitro.
    Butorov EV
    Antivir Chem Chemother; 2015 Feb; 24(1):39-46. PubMed ID: 26149265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon and interferon inhibitor levels in patients infected with varicella-zoster virus, acquired immunodeficiency syndrome, acquired immunodeficiency syndrome-related complex, or Kaposi's sarcoma, and in normal individuals.
    Ambrus JL; Poiesz BJ; Lillie MA; Stadler I; Di Berardino LA; Chadha KC
    Am J Med; 1989 Oct; 87(4):405-7. PubMed ID: 2478016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of HIV-1 activated leukocyte adhesion mechanisms and matrix metalloproteinase secretion in AIDS pathogenesis (Review).
    Weeks BS
    Int J Mol Med; 1998 Feb; 1(2):361-6. PubMed ID: 9852238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxyradical-mediated clastogenic plasma factors in psoriasis: increase in clastogenic activity after PUVA.
    Filipe P; Emerit I; Alaoui Youssefi A; Levy A; Cernjavski L; Freitas J; de Castro JL
    Photochem Photobiol; 1997 Oct; 66(4):497-501. PubMed ID: 9337621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta.
    Varthakavi V; Smith RM; Deng H; Sun R; Spearman P
    Virology; 2002 Jun; 297(2):270-80. PubMed ID: 12083825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of antitat gene therapy in the presence of high multiplicity infection and inflammatory cytokines.
    Lisziewicz J; Sun D; Gallo RC; Ensoli B; Lori F
    Hum Gene Ther; 1996 Dec; 7(18):2209-16. PubMed ID: 8953311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling.
    Zeng Y; Zhang X; Huang Z; Cheng L; Yao S; Qin D; Chen X; Tang Q; Lv Z; Zhang L; Lu C
    J Virol; 2007 Mar; 81(5):2401-17. PubMed ID: 17151125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.